Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
OPERATING ACTIVITIES    
Net loss $ (2,300,196) $ (45,611)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation and amortization 767,254 0
Amortization of debt discount 210,526 0
Bad debts 400,000 0
Loss on equity investment 310,754 0
Stock issued pursuant to employment agreement 5,650 0
Change in operating assets and liabilities:    
Prepaid expense (174,317) 1,750
Prepaid inventory (474,321) 0
Inventory (2,127,845) 0
Accounts receivable (1,744,064) 0
Accounts payable 24,622 (20,223)
Accrued expenses 222,703 0
Net cash flows used in operating activities (4,879,234) (64,084)
INVESTING ACTIVITIES    
Cash received on acquisition (Note 5) 50,775 0
Purchase of equipment (226,594) 0
Cash paid on PhytoSPHERE agreement (Note 5) (950,000) 0
Investment in KanaLife Sciences (Note 2) (750,000) 0
Net cash flows from investing activities (1,875,819) 0
FINANCING ACTIVITIES    
Proceeds from related party loans 0 63,347
Proceeds from loan from Roen Ventures, LLC (Note 7) 6,192,069 0
Repayment of loan to Roen Ventures, LLC (Note 7) (100,000) 0
Repayment of loan from related party (200) 0
Common stock to be issued 175,000 0
Cash from sale of stock (net of expenses) 2,731,423 0
Net cash flows from financing activities 8,998,292 63,347
Net increase (decrease) in cash 2,243,239 (737)
Cash, beginning of year 431 1,168
Cash, end of year 2,243,670 431
Supplementary cash flow disclosures:    
Income taxes paid 0 0
Interest paid 0 0
Supplementary disclosures of non-cash transactions:    
Value of debt discount 800,000 0
Accounts receivable assumed from acquisition 396,438 0
Inventory assumed from acquisition 345,477 0
Prepaid inventory assumed from acquisition 1,260,510 0
Property and equipment assumed from acquisition 1,288 0
Intangible assets 4,110,000 0
Goodwill 1,855,512 0
Common stock issued for acquisition $ 7,070,000 $ 0